Top Markets
Coin of the day
Jyong Biotech Ltd. Ordinary Shares Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. Ordinary Shares

MENS
Rangering i aksjer #19259
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the... Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably features MCS-2, currently undergoing Phase III trials for benign prostatic hyperplasia (BPH); PCP, which is in Phase II development for prostate cancer; and IC, presently in pre-clinical stages.
Aksjekurs
$2.22
Sist synkronisert: 2026-08-25
Markedsverdi
$168.64M
Endring (1 dag)
-0.09%
Endring (1 år)
-95.58%
Land
TW
Handel Jyong Biotech Ltd. Ordinary Shares (MENS)

Kategori

P/B-forhold for Jyong Biotech Ltd. Ordinary Shares (MENS)
P/B-forhold per 2026 TTM: 0
Ifølge Jyong Biotech Ltd. Ordinary Shares sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Jyong Biotech Ltd. Ordinary Shares fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH